TKG Has Scheduled a Live Webcast on Paragraph IV Challenges: Exploring Emerging Trends
Filing a Paragraph IV (PIV) patent challenge remains to be one of generic drug manufacturers' strategies to gain entry into the market before the patents' expiration. Although pursuing a challenge presents significant business opportunities, it poses additional complexities. In the context of medical diagnostics and methods of treatment claims, these challenges include divided infringement and Section 101 problems.
Counsel to both brand and generic companies should be prepared with the emergence of new developments that will shape the Paragraph IV litigation landscape, particularly claims directed to diagnostics and methods of treatment.
Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they bring the audience to a road beyond the basics of pursuing or defending against a paragraph IV challenge and as they delve into an in-depth analysis of the current trends and recent filings. Speakers will also provide the audience with the best litigation practices and practical strategies to help their clients cope with the evolving legal climate.
Key topics include:
• Section 101 Patentability Challenges - Recent Developments for Method of Treatment Patent Claims
• Courts' Application of the Mayo Two-Part Test
• Divided Infringement in Medical Diagnostics and Methods of Treatment Claims
• The Akamai test
• Best Litigation Practices and Practical Tips
Gregory B. Sephton, Ph.D.
Pierce Bainbridge Beck Price & Hecht LLP
Pablo D. Hendler
For an updated list of the faculty panel, please visit: https://www.theknowledgegroup.org/
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Group, LLC brings together the world's leading authorities and industry participants through informative two-hour webcasts that study the impact of changing regulations and help businesses succeed through proper regulatory compliance.